FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

2191000221103: Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3944037016 Inactivated rabies vaccine grown in cellular line en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3944038014 Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) en Fully specified name Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3951625012 Inactivated whole Rabies lyssavirus antigen grown in cellular line only vaccine product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) Is a Vaccine product containing only inactivated whole Rabies lyssavirus antigen true Inferred relationship Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) Plays role Active immunity stimulant role (role) true Inferred relationship Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) Has active ingredient Antigen of inactivated whole Rabies lyssavirus grown in cellular line (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start